REVLIMID Trademark

Trademark Overview

On Monday, February 14, 2005, a trademark application was filed for REVLIMID with the United States Patent and Trademark Office. The USPTO has given the REVLIMID trademark a serial number of 76631301. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, January 23, 2016. This trademark is owned by Celgene Corporation. The REVLIMID trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
revlimid

General Information

Serial Number76631301
Word MarkREVLIMID
Filing DateMonday, February 14, 2005
Status800 - REGISTERED AND RENEWED
Status DateSaturday, January 23, 2016
Registration Number3169244
Registration DateTuesday, November 7, 2006
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 3, 2006

Trademark Statements

Description of the Colors ClaimedThe colors blue and yellow appear in the mark as follows: the lettering is blue, the design consists of two curved bands with sections on different teardrop shapes, the band starting at the top of the first I is blue, the other band running the opposite direction is yellow.
Goods and Servicespharmaceutical preparations, namely cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Indication of Colors claimedThe color(s) yellow and blue are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 4, 2005
Primary Code005
First Use Anywhere DateWednesday, November 30, 2005
First Use In Commerce DateWednesday, November 30, 2005

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 6, 2019NOTICE OF SUIT
Saturday, January 23, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, January 23, 2016REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, January 23, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, January 23, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 9, 2015TEAS SECTION 8 & 9 RECEIVED
Saturday, November 7, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 21, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, December 21, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, December 21, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 8, 2011TEAS SECTION 8 & 15 RECEIVED
Tuesday, November 7, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, September 28, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 25, 2006ASSIGNED TO LIE
Wednesday, September 20, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, September 16, 2006STATEMENT OF USE PROCESSING COMPLETE
Monday, August 14, 2006USE AMENDMENT FILED
Monday, August 14, 2006TEAS STATEMENT OF USE RECEIVED
Tuesday, July 18, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 1, 2006EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, January 31, 2006EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 3, 2006PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2005NOTICE OF PUBLICATION
Wednesday, November 9, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 4, 2005ASSIGNED TO LIE
Wednesday, November 2, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 1, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 24, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 24, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 12, 2005CORRESPONDENCE MAILED
Wednesday, October 12, 2005FINAL REFUSAL WRITTEN
Thursday, September 29, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 19, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 19, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 14, 2005NON-FINAL ACTION MAILED
Tuesday, September 13, 2005NON-FINAL ACTION WRITTEN
Monday, September 12, 2005ASSIGNED TO EXAMINER
Friday, March 4, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

revlimid pharmaceutical preparations immune system modulate inhibitory namely cytokine drugs